ADHD In The News13

Australia’s 2025–26 Health Budget promises major investment, but behind the headlines are offsets, extensions and unanswered questions shaping Medicare, mental health, research and care access.

How Australia’s ADHD Guideline and Prescribing Guides were developed, independently validated by NHMRC, and protected from industry influence through transparent, evidence?based processes.

Australia needs national consistency in ADHD care built on evidence, training and patient safety — not slogans or fragmented reform. AADPA explains why standards matter.

AADPA is calling upon Health Minister, Mark Butler, to ensure ADHD is included as a key driver of the Thriving Kids program and not left as an afterthought.

AADPA welcomes breakthrough reforms empowering trained GPs in NSW to prescribe ongoing treatment for ADHD patients

The first-ever Lancet Series on ADHD brings together an extraordinary coalition of experts from sixteen countries, led by AADPA President, Prof. David Coghill.

With the current global shortage of lisdexamfetamine, AADPA lodged a submission to the US Drug Enforcement Agency in response to their call for feedback regarding the restriction of production quotas…

The Australian ADHD Professionals Association welcomes and supports the 15 key recommendations contained in the Senate Report released on Monday.

Read AADPA's Senate Inquiry submission based on evidence from the ADHD Clinical Practice Guideline which includes a call to develop a National ADHD Strategy.